Viemed Healthcare, Inc.
VMD
$7.80
$0.405.41%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.54% | 26.22% | 31.75% | 32.79% | 31.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.54% | 26.22% | 31.75% | 32.79% | 31.82% |
| Cost of Revenue | 29.66% | 28.57% | 30.67% | 31.95% | 29.68% |
| Gross Profit | 18.11% | 24.73% | 32.44% | 33.33% | 33.19% |
| SG&A Expenses | 20.17% | 24.72% | 29.65% | 27.20% | 27.31% |
| Depreciation & Amortization | 6.61% | 31.39% | 53.74% | 54.29% | 37.45% |
| Other Operating Expenses | -641.84% | -219.27% | -81.73% | 89.98% | 87.58% |
| Total Operating Expenses | 23.50% | 25.75% | 29.46% | 29.10% | 28.57% |
| Operating Income | 11.97% | 31.86% | 64.05% | 95.79% | 82.27% |
| Income Before Tax | 12.36% | 15.83% | 34.51% | 70.50% | 60.08% |
| Income Tax Expenses | 14.78% | 21.22% | 48.53% | 65.02% | 49.86% |
| Earnings from Continuing Operations | 11.38% | 13.67% | 29.10% | 72.81% | 64.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.98% | 13.28% | 28.98% | 72.81% | 64.63% |
| EBIT | 11.97% | 31.86% | 64.05% | 95.79% | 82.27% |
| EBITDA | 14.36% | 26.29% | 43.89% | 56.34% | 54.69% |
| EPS Basic | 8.55% | 11.93% | 27.61% | 71.61% | 65.61% |
| Normalized Basic EPS | -2.44% | 13.67% | 41.87% | 80.41% | 68.99% |
| EPS Diluted | 14.58% | 10.09% | 18.90% | 64.95% | 64.60% |
| Normalized Diluted EPS | -2.52% | 13.88% | 41.70% | 78.10% | 65.64% |
| Average Basic Shares Outstanding | 1.32% | 1.29% | 1.14% | 0.52% | -0.80% |
| Average Diluted Shares Outstanding | 1.20% | 1.04% | 1.34% | 2.01% | 1.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
